← back to database
OrbiMed invests globally across health care, from seed-stage startups to large public companies. Its private-equity strategy backs biopharmaceutical, medical-device, diagnostic, health-care-service, and digital-health companies and typically acts as a lead investor.
Primary stage
Lead / follow
Initial check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
Approximately $20B AUM
Investing team
- Sven H. BorhoManaging Partner
- Carl L. GordonManaging Partner
- W. Carter NeildManaging Partner
- Geoffrey C. HsuGeneral Partner
- C. Scotland StevensGeneral Partner
- David BonitaGeneral Partner
- Matthew RizzoGeneral Partner
- Peter ThompsonGeneral Partner
- Mona AshiyaGeneral Partner